HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Suthat Fucharoen Selected Research

Thalassemia

8/2015Accelerated telomere shortening in β-thalassemia/HbE patients.
6/2015Validation of the immunochromatographic strip for α-thalassemia screening: a multicenter study.
4/2015Discrimination of various thalassemia syndromes and iron deficiency and utilization of reticulocyte measurements in monitoring response to iron therapy.
1/2015Treatment of β-Thalassemia/Hemoglobin E with Antioxidant Cocktails Results in Decreased Oxidative Stress, Increased Hemoglobin Concentration, and Improvement of the Hypercoagulable State.
1/2015Platelet hyperactivity in thalassemia patients with elevated tricuspid regurgitant velocity and the association with hemolysis.
1/2015Effects of Iron Chelators on Pulmonary Iron Overload and Oxidative Stress in β-Thalassemic Mice.
9/2014Iron distribution and histopathological characterization of the liver and heart of β-thalassemic mice with parenteral iron overload: Effects of deferoxamine and deferiprone.
9/2013Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.
9/2013Decreased nitrite levels in erythrocytes of children with β-thalassemia/hemoglobin E.
8/2013Enhanced erythroid cell differentiation in hypoxic condition is in part contributed by miR-210.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Suthat Fucharoen Research Topics

Disease

46Thalassemia
08/2015 - 06/2002
39beta-Thalassemia (Cooley's Anemia)
01/2012 - 06/2002
21Iron Overload
05/2015 - 11/2003
14alpha-Thalassemia
02/2012 - 05/2002
9Anemia
01/2016 - 10/2002
7Hemoglobinopathies
01/2016 - 02/2002
6Hydrops Fetalis (Fetal Edema)
06/2015 - 06/2005
5Infection
08/2015 - 07/2003
5Heart Failure
01/2014 - 09/2007
4Hemolysis
01/2015 - 09/2009
3Anoxia (Hypoxia)
02/2015 - 01/2012
3Cardiomyopathies (Cardiomyopathy)
07/2011 - 02/2011
3Atherosclerosis
01/2007 - 01/2006
2Body Weight (Weight, Body)
01/2015 - 05/2009
2Neoplasms (Cancer)
06/2014 - 03/2009
2Stroke (Strokes)
01/2014 - 04/2011
2Leukemia
03/2011 - 03/2009
2Congenital Hemolytic Anemia (Hemolytic Anemia, Congenital)
04/2009 - 01/2004
1Malaria
08/2015
1Fibrosis (Cirrhosis)
01/2015
1Wounds and Injuries (Trauma)
01/2015
1Hypertrophy
09/2014
1Siderosis
01/2014
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2014
1Acute Erythroblastic Leukemia (Erythroleukemia)
12/2012
1Polycythemia (Erythrocytosis)
11/2012
1Hyperplasia
09/2009

Drug/Important Bio-Agent (IBA)

32IronIBA
05/2015 - 11/2003
28Hemoglobin EIBA
01/2015 - 06/2002
23Hemoglobins (Hemoglobin)IBA
06/2015 - 08/2002
21GlobinsIBA
01/2016 - 12/2002
11alpha-GlobinsIBA
02/2012 - 06/2005
9beta-Globins (beta Globin)IBA
09/2009 - 08/2002
8deferiprone (CP20)IBA
05/2015 - 01/2006
6hemoglobin Bart'sIBA
06/2015 - 06/2005
6Deferoxamine (Desferal)FDA LinkGeneric
05/2015 - 01/2006
5DNA (Deoxyribonucleic Acid)IBA
10/2010 - 08/2002
4Chelating AgentsIBA
05/2015 - 03/2009
4Transferrin (beta 2 Transferrin)IBA
08/2013 - 01/2006
4Ferritins (Ferritin)IBA
08/2013 - 01/2007
4Fetal Hemoglobin (Hemoglobin F)IBA
11/2009 - 12/2005
4Lipoproteins (Lipoprotein)IBA
04/2009 - 01/2006
3MicroRNAs (MicroRNA)IBA
08/2015 - 10/2010
3Biological Markers (Surrogate Marker)IBA
08/2015 - 01/2007
3Proteins (Proteins, Gene)IBA
01/2014 - 01/2007
3ProteomeIBA
03/2013 - 12/2012
3ErythropoietinFDA Link
12/2012 - 09/2007
3Malondialdehyde (Propanedial)IBA
06/2012 - 01/2005
3Carbon MonoxideIBA
02/2012 - 01/2006
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2012 - 01/2011
3gamma-GlobinsIBA
08/2010 - 06/2006
3RNA Precursors (Precursor, mRNA)IBA
01/2009 - 09/2002
3Messenger RNA (mRNA)IBA
09/2007 - 09/2002
3Codon (Codons)IBA
04/2005 - 10/2002
2deferasiroxFDA Link
05/2015 - 10/2011
2Isoflurophate (DFP)FDA Link
05/2015 - 10/2011
2Hemoglobin Constant SpringIBA
04/2015 - 06/2002
2AntioxidantsIBA
01/2015 - 01/2007
2Dextrans (Dextran)FDA Link
01/2015 - 09/2014
2AntibodiesIBA
12/2014 - 06/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2014 - 06/2002
2tebufenozide (Mimic)IBA
09/2014 - 01/2005
2Glutathione (Reduced Glutathione)IBA
01/2013 - 01/2007
2Caspase 3 (Caspase-3)IBA
03/2011 - 03/2009
2Dietary IronIBA
10/2008 - 01/2006
2Acetaminophen (Paracetamol)FDA LinkGeneric
01/2007 - 09/2006
2Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA
01/2007 - 09/2006
2Hydroxyurea (Hydrea)FDA LinkGeneric
03/2006 - 12/2005
1Mi-2 Nucleosome Remodeling and Deacetylase ComplexIBA
01/2016
1Insulin (Novolin)FDA Link
12/2015
1Glycoproteins (Glycoprotein)IBA
01/2015
1Idiopathic pulmonary hypertensionIBA
01/2015
1P-SelectinIBA
01/2015
1CatalaseIBA
01/2015
1Caspase 8 (Caspase-8)IBA
12/2014
1deoxyhemoglobinIBA
01/2014
1OxygenIBA
08/2013
1ADP-Ribosylation Factors (ADP-Ribosylation Factor)IBA
03/2013
1endothelin-converting enzymeIBA
03/2013
1Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA
03/2013
1Glutathione Disulfide (GSSG)FDA LinkGeneric
01/2013
1mitochondrial calcium uniporterIBA
12/2012
1ferroceneIBA
06/2012
1L-Type Calcium Channels (Dihydropyridine Receptor)IBA
06/2012
1Vitamin EFDA LinkGeneric
01/2012
1AsparagineIBA
07/2011
1RNA (Ribonucleic Acid)IBA
07/2011
1CytokinesIBA
03/2011
1InterferonsIBA
03/2011
1TunicamycinIBA
05/2010
1DNA AdductsIBA
08/2009

Therapy/Procedure

8Blood Transfusion (Blood Transfusions)
09/2014 - 10/2002
2Immunotherapy
06/2014 - 03/2011
2Splenectomy
01/2013 - 11/2012
1Intraperitoneal Injections
01/2015
1Heart Transplantation (Grafting, Heart)
01/2014
1Aftercare (After-Treatment)
03/2013
1Chelation Therapy (Therapy, Chelation)
10/2011
1Transplantation (Transplant Recipients)
04/2011
1Therapeutics
08/2010